STAT+: Nonprofit health systems plug their strong cash reserves at JPM — a very different pitch than they make elsewhere
SAN FRANCISCO — Hospital leaders spent a good chunk of their stage time at the…
Category: Medicine
STAT+: New congressional bill would thwart patent thickets in order to speed generic drugs to market
In the latest bid to lower the cost of medicines, a new bill was introduced…
STAT+: Fiery MedPAC meeting highlights massive overpayments in Medicare Advantage
Medicare Advantage is arguably the most controversial health care program right now — a sentiment…
STAT+: Pharmalittle: We’re reading about GLP-1 drugs’ safety, Novartis nixing a deal, and more
And so, another working week will soon come to a close. Not a moment too…
As she drives research on structural racism in health care, Rachel Hardeman faces a painful reckoning
MINNEAPOLIS — It’s been almost four years since George Floyd was murdered here at 38th…
Opinion: The nursing staffing crisis has hit one role particularly hard: the nurse manager
Though the Covid-19 pandemic brought heightened attention to nurses overall, a unique nursing role has…
New York’s new doula plan will cover services for anyone on Medicaid
NEW YORK — During the peak of Covid-19 lockdown restrictions, Kendra Berger delivered her second…
STAT Virtual Event | 2024 JPM Recap, Live!
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
In partial reversal, Texas Medicaid greenlights first step in gene therapy for Afghan refugees’ infant son
The Pashai family of Dallas on Thursday got some good news, but not exactly the…
The highs — and lows — of JPM 2024 you should pay attention to
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
Opinion: Pumping milk at JPM was a nightmare. It’s part of a bigger problem in the industry
Since having a baby 10 months ago, I’ve learned many things. Chief among them: Pumping…
STAT+: Rune Labs, which makes an app to track Parkinson’s symptoms, raises $12 million
Rune Labs, maker of an Apple Watch app that can track symptoms related to Parkinson’s…
GLP-1 drugs not linked to suicidal thoughts, FDA’s early review finds
A preliminary evaluation by the Food and Drug Administration did not find evidence that GLP-1…
Listen: Live! From JPM 2024
Is biotech back from its downturn? Can Nvidia solve biology? And is it wise to…
Accolade beats analyst estimates, Teladoc’s optimism, and more JPM health tech news
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology…
STAT+: Pharmalittle: We’re reading about FDA’s syphillis-drug plan, India’s manufacturer-inspection demands, and more
Rise and shine, another busy day is on the way. However, this is also shaping…
Patients’ social needs often get lost in health records. Generative AI could help
Generative AI’s earliest applications in medicine have largely focused on curing not patients, but the…
STAT+: Courts will decide the future of Medicare’s power to negotiate drug prices within months
WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare…
STAT+: A biotech reporter’s notebook: Sunshine rains down on San Francisco
SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan…
Opinion: How to ensure the NIH’s decision to recognize people with disabilities as a health disparity population makes a difference
My daughter Katie was born with severe disabilities. She went on to develop profound autism,…
STAT+: U.K. sequencing study surfaces new findings about tumor DNA
LONDON — A decade ago, the U.K. launched its 100,000 Genomes Project, a major research…
STAT+: Contributors to psychiatry’s bible, the DSM-5, got $14 million from industry
Amid ongoing concerns over conflicts of interest, a new study found that 60% of the…
JPM Day 3 had a cautiously optimistic outlook
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
STAT+: At JPM, Verve details plot to take genome editing mainstream
SAN FRANCISCO — The promise of genome editing has given rise to potentially curative medicines…
After grilling Fauci on Covid origins, House Republicans want to consider new rules for foreign research
WASHINGTON — House Republicans want to explore tighter inspection and safety requirements for infectious disease…
STAT+: Heated lawsuit between AdventHealth, MultiPlan attracts hospital lobbyists
A lawsuit between a large hospital system and a dominant vendor that works for health…
Nearly 1 in 10 global teens have used “budget Ozempic” laxatives and other risky weight-loss products, per study
New weight loss medications like Ozempic and Wegovy have garnered a lot of attention in…
STAT+: Pharmalittle: We’re reading about Sanofi’s Olympics bet, Singulair problems, and more
Good morning, everyone, and how are you today? We are doing just fine, thank you….
Advocates expect Supreme Court Idaho abortion decision to fuel efforts to further restrict access
The U.S. Supreme Court’s decision to consider the legality of Idaho’s abortion law — and…
STAT+: Bayer’s promising menopause drug trial results highlight growing interest in long-neglected condition
More hopeful news on the menopause front: Bayer announced on Monday encouraging results in two…
Opinion: Preventing health care violence in the ER requires moving from safety to security
A slight man falls off his barstool. Now he’s an ER patient, slurring insults and…
STAT+: Morgan Health wants you to know it’s still here
SAN FRANCISCO — Almost three years ago, the country’s biggest bank unveiled a lofty plan…
JPM Day 2 has arrived. Here are the can’t-miss moments of the event so far
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
STAT+: FDA’s Peter Marks seems inclined to grant full approval to Sarepta’s Duchenne gene therapy
SAN FRANCISCO — Peter Marks, the Food and Drug Administration’s top regulator of gene therapies,…
.jpg)
Anthony Fauci talked Covid in Congress in a nine-hour, closed-door grilling — and that was just day one
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Pharmalittle: We’re reading about a GSK deal, a probe into inhaler prices, and more
Rise and shine, everyone, another busy day is on the way. We can tell by…
STAT+: Nvidia says a biological revolution is happening now. But is it?
SAN FRANCISCO — The small hotel meeting room was packed like a rush hour subway….
STAT+: JPM 2024: FogPharma’s new CEO, Mathai Mamman, unveils ‘contrarian’ plan in oncology
SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai…
STAT+: Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution
Researchers attending gene therapy meetings over the past couple years were liable to bump into…
STAT+: HHS’s Xavier Becerra, once an ‘invisible’ secretary, is racing to cement a clearer legacy
WASHINGTON — He’s been called the “invisible” secretary. So far removed from the White House…
The Afghan father aided U.S. soldiers. Now Texas Medicaid won’t pay for his son’s gene therapy
On a sweltering day in August 2021, as the engines of a hulking C-17 cargo…
Opinion: Sen. Maggie Hassan on what Congress must do next to fight the opioid crisis
Few public health challenges have been more daunting and persistent than the opioid crisis, which…
STAT+: GSK to acquire Aiolos Bio in $1.4 billion deal, picking up an experimental asthma drug
LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for…
STAT+: Mayo Clinic partners with supercomputing startup Cerebras to build custom AI tools
SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first…
STAT+: Hospitals try a new pitch to investors: other ways of making money
SAN FRANCISCO — If you learned anything about nonprofit hospitals on the first day of…
This is the TLDR of JPM Day 1
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
UnitedHealth’s next physician acquisition & the January health insurance churn
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
STAT+: Florida faces ‘complicated road’ before actually importing drugs from Canada, expert says
Last week, the Food and Drug Administration granted Florida permission to import medicines from Canada,…
STAT+: CVS Health sees Medicare Advantage patients seek more care, eating into profits
Medicare Advantage members continue to go to the doctor and get health care procedures a…
STAT+: Sen. Sanders, others lawmakers open probe into asthma inhaler makers over pricing, patent maneuvers
Several U.S. lawmakers including Sen. Bernie Sanders (I-Vt.) are investigating the prices charged by four…